UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 127

Sortiert nach

Commentary on Donoghue: Low prescribing rates of pharmacotherapy for alcohol use disorder limit potential public health impact

Addiction (Abingdon, England), 2021-11, Vol.116 (11), p.3027-3028

Morley, Kirsten C.

2021

Volltextzugriff (PDF)

Commentary on Aubin et al.: Could combination medication approaches target mental health comorbidity in the context of alcohol use disorder?

Addiction (Abingdon, England), 2024-07, Vol.119 (7), p.1224-1225

2024

Volltextzugriff (PDF)

Alcohol use disorder and circulating cytokines: A systematic review and meta-analysis

Brain, behavior, and immunity, 2020-10, Vol.89, p.501-512

2020

Volltextzugriff (PDF)

Pharmacotherapeutic agents in the treatment of methamphetamine dependence

Expert opinion on investigational drugs, 2017-05, Vol.26 (5), p.563-578

2017

Volltextzugriff (PDF)

Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial

British journal of psychiatry, 2018-06, Vol.212 (6), p.362-369

2018

Volltextzugriff (PDF)

A systematic review of evidence-based practice implementation in drug and alcohol settings: applying the consolidated framework for implementation research framework

Implementation science : IS, 2021-03, Vol.16 (1), p.22-29, Article 22

2021

Volltextzugriff (PDF)

Psychosocial Interventions for Reducing Suicidal Behaviour and Alcohol Consumption in Patients With Alcohol Problems: A Systematic Review of Randomized Controlled Trials

Alcohol and alcoholism (Oxford), 2021-01, Vol.56 (1), p.17-27

2021

Volltextzugriff (PDF)

Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial

The American journal of psychiatry, 2024-05, Vol.181 (5), p.403

2024

Volltextzugriff (PDF)

Treatment of alcohol problems: current status and future directions

Medical journal of Australia, 2021-10, Vol.215 (7), p.315-316

2021

Volltextzugriff (PDF)

National trends in alcohol pharmacotherapy: Findings from an Australian claims database

Drug and alcohol dependence, 2016-09, Vol.166, p.254-257

2016

Volltextzugriff (PDF)

N acetylcysteine in the treatment of alcohol use disorder: a randomized, double-blind, placebo-controlled trial

Alcohol and alcoholism (Oxford), 2023-09, Vol.58 (5), p.553-560

2023

Volltextzugriff (PDF)

Economic evaluations of alcohol pharmacotherapy: Systematic review of economic evaluations of pharmacotherapy for the treatment of alcohol use disorder

Australian & New Zealand Journal of Psychiatry, 2024-02, Vol.58 (2), p.117-133

2024

Volltextzugriff (PDF)

New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies

Expert opinion on pharmacotherapy, 2021-07, Vol.22 (10), p.1291-1303

2021

Volltextzugriff (PDF)

Baclofen attenuates fMRI alcohol cue reactivity in treatment-seeking alcohol dependent individuals

Psychopharmacology, 2021-05, Vol.238 (5), p.1291-1302

2021

Volltextzugriff (PDF)

Assessing the validity of the Wechsler Adult Intelligence Scale (WAIS-IV) in predicting completion in a long-term residential rehabilitation for substance use problems

Applied neuropsychology. Adult, 2023-09, Vol.30 (5), p.561-566

2023

Volltextzugriff (PDF)

Moderation of baclofen response by a GABAB receptor polymorphism: results from the BacALD randomized controlled trial

Addiction (Abingdon, England), 2018-12, Vol.113 (12), p.2205-2213

2018

Volltextzugriff (PDF)

Central markers of neuroinflammation in alcohol use disorder: A meta‐analysis of neuroimaging, cerebral spinal fluid, and postmortem studies

Alcohol (Hanover, York County, Pa.), 2023-02, Vol.47 (2), p.197-208

2023

Volltextzugriff (PDF)

Impaired Decision-Making and Skin Conductance Responses Are Associated with Reward and Punishment Sensitivity in Individuals with Severe Alcohol Use Disorder

Neuropsychobiology, 2023-04, Vol.82 (2), p.117-129

2023

Volltextzugriff (PDF)

Insomnia and excessive daytime sleepiness in women and men receiving methadone and buprenorphine maintenance treatment

Substance use & misuse, 2019-08, Vol.54 (10), p.1589-1598

2019

Volltextzugriff (PDF)

A Review of Baclofen Overdoses in Australia: Calls to a Poisons Information Centre and a Case Series

Alcohol and alcoholism (Oxford), 2019-01, Vol.54 (1), p.73-78

2019

Volltextzugriff (PDF)

Clinical Predictors of Response to Baclofen in the Treatment of Alcohol use Disorder: Results from the BacALD Trial

Alcohol and alcoholism (Oxford), 2019-05, Vol.54 (3), p.272-278

2019

Volltextzugriff (PDF)

Brain GABA levels are reduced in alcoholic liver disease: A proton magnetic resonance spectroscopy study

Addiction biology, 2020-01, Vol.25 (1), p.e12702-n/a

2020

Volltextzugriff (PDF)

A systematic review of the perceptions and attitudes of mental health nurses towards alcohol and other drug use in mental health clients

International journal of mental health nursing, 2022-12, Vol.31 (6), p.1373-1389

2022

Volltextzugriff (PDF)

High-dose baclofen attenuates insula activation during anticipatory anxiety in treatment-seeking alcohol dependant individuals: Preliminary findings from a pharmaco-fMRI study

European neuropsychopharmacology, 2021-05, Vol.46, p.28-36

2021

Volltextzugriff (PDF)

Sex as a Potential Moderator for Baclofen Response in the Treatment of Alcohol Dependence

Frontiers in Global Women's Health, 2022-03, Vol.3, p.807269-807269

2022

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(115)

Publikationsform

Sprache

Englisch
(126)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Commentary on Donoghue: Low prescribing rates of pharmacotherapy for alcohol use disorder limit potential public health impact

Commentary on Aubin et al.: Could combination medication approaches target mental health comorbidity in the context of alcohol use disorder?

Alcohol use disorder and circulating cytokines: A systematic review and meta-analysis

Pharmacotherapeutic agents in the treatment of methamphetamine dependence

Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial

A systematic review of evidence-based practice implementation in drug and alcohol settings: applying the consolidated framework for implementation research framework

Psychosocial Interventions for Reducing Suicidal Behaviour and Alcohol Consumption in Patients With Alcohol Problems: A Systematic Review of Randomized Controlled Trials

Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial

Treatment of alcohol problems: current status and future directions

National trends in alcohol pharmacotherapy: Findings from an Australian claims database

N acetylcysteine in the treatment of alcohol use disorder: a randomized, double-blind, placebo-controlled trial

Economic evaluations of alcohol pharmacotherapy: Systematic review of economic evaluations of pharmacotherapy for the treatment of alcohol use disorder

New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies

Baclofen attenuates fMRI alcohol cue reactivity in treatment-seeking alcohol dependent individuals

Assessing the validity of the Wechsler Adult Intelligence Scale (WAIS-IV) in predicting completion in a long-term residential rehabilitation for substance use problems

Moderation of baclofen response by a GABAB receptor polymorphism: results from the BacALD randomized controlled trial

Central markers of neuroinflammation in alcohol use disorder: A meta‐analysis of neuroimaging, cerebral spinal fluid, and postmortem studies

Impaired Decision-Making and Skin Conductance Responses Are Associated with Reward and Punishment Sensitivity in Individuals with Severe Alcohol Use Disorder

Insomnia and excessive daytime sleepiness in women and men receiving methadone and buprenorphine maintenance treatment

A Review of Baclofen Overdoses in Australia: Calls to a Poisons Information Centre and a Case Series

Clinical Predictors of Response to Baclofen in the Treatment of Alcohol use Disorder: Results from the BacALD Trial

Brain GABA levels are reduced in alcoholic liver disease: A proton magnetic resonance spectroscopy study

A systematic review of the perceptions and attitudes of mental health nurses towards alcohol and other drug use in mental health clients

High-dose baclofen attenuates insula activation during anticipatory anxiety in treatment-seeking alcohol dependant individuals: Preliminary findings from a pharmaco-fMRI study

Sex as a Potential Moderator for Baclofen Response in the Treatment of Alcohol Dependence

Suchergebnisse filtern